Standout Papers

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in mod... 2010 2026 2015 2020 1.1k
  1. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy (2010)
    Lee Honigberg, Ashley M. Smith et al. Proceedings of the National Academy of Sciences

Immediate Impact

4 by Nobel laureates 11 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

Remibrutinib in Chronic Spontaneous Urticaria
2025 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
24 intermediate papers

Works of Ashley M. Smith being referenced

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
2010 Standout

Author Peers

Author Last Decade Papers Cites
Ashley M. Smith 803 56 263 555 432 14 1.4k
Ann M. Lowe 568 12 251 486 411 11 1.4k
Günter Brittinger 655 29 421 878 253 27 1.5k
Sarah E.M. Herman 1097 279 710 703 21 1.6k
Christian R. Geest 449 5 158 297 470 16 1.0k
Amber Gordon 1150 3 328 775 427 13 1.4k
Jacques‐Louis Binet 1300 26 276 1122 217 20 1.7k
Julie A. Losman 229 3 513 184 628 11 1.3k
Sílvia Marcé 1084 18 300 863 451 20 1.6k
Lori A. Gressick 1020 15 465 753 591 13 1.6k
Polly Pine 239 13 350 155 330 22 1.6k

All Works

Loading papers...

Rankless by CCL
2026